# Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fed Conditions

> **NCT00939367** · PHASE1 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zolpidem Tartrate Tablets 10 mg
- **DRUG:** 'Sanofi-Synthelabo Inc's Ambien® Tablets 10 mg

## Key facts

- **NCT ID:** NCT00939367
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-24
- **Primary completion:** 2007-05-02
- **Final completion:** 2007-05-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939367, "Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00939367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*